Published in Telemedicine Business Week, March 17th, 2010
"The present study evaluates the reversal of diabetes-mediated impairment of angiogenesis in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Telemedicine Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.